Menuration is something that passes through every woman. As fertility disappears, estrogen and progesterone levels decline significantly – changes that may affect physical health, emotional fitness and on a regular basis life.
This hormonal shift effects are greater than disappointing – they will change life. Symptoms similar to cerebral fog, hot flushes, night sweat, headache, insomnia, fatigue, joint pain, low albedo, anxiety, depression and even osteoporosis are all common symptoms.
Hormone Replause therapy (HRT) has helped many ladies handle these symptoms – but a key hormone is usually ignored in each treatment and conversation: testosterone.
Testosterone is often seen as “male hormone”, nevertheless it also plays a crucial role in women's health. In fact, There is a high level in women Testosterone for many of their adult life than estrogen or progesterone. And other sex hormones, like testosterone Also decreases with age – With the outcomes which are now being fully discovered only.
The difference of testosterone
Hormone replacement therapy (HRT) is now widely used to exchange estrogen and progesterone during and after menopause. These treatments-gallows, patchs, gels and can be found as implants-regular, evidence-based and rapidly accessible Through NHS.
But in terms of testosterone, the situation is kind of different.
Currently, there are No testosterone product is licensed Women's use within the UK or Europe. The only exception is in Australia, where a testosterone cream is Is specifically designed for women Available. Once Europe had its own option – a transider patch called entry, which is designed and approved by regulators based on clinical evidence, which may cure less albedo in surgical -induced epidemic women. But manufacturer Withdrawn the product in 2012Referring to “commercial reservations” In their letter to European Medicine AgencyDiagnosis and monitoring of pharmaceutical products in Europe.
Since then, women from throughout Europe have been left without approved option.
I Absence of licensed treatmentSome physicians – mainly in private practice – testosterone “off -label”, often use men's products. These are frequently gel or cream The dose is several times higher Most women excessively needed. Although a health care provider may advise to regulate the dose, such a correction comes with the risks: incorrect dose, inconsistent absorption and lack of long -term protective data.
Some women are notified Significant improvement – Not only in albedo, but additionally in brain fog, mood, joint pain and energy levels. However, Only proven medical advantage In women is in testosterone Improving sexual desire After surgical menopause, individuals with hyperactive sexual desire (HSDD).
Nevertheless, interest is growing – fuel From the patient's demandFor, for, for,. The use of celebrityFor, for, for,. Social Media Buzz And a growing feeling that testosterone could be one Missing piece in mid -life women care.
While there may be Increase in consensus This testosterone can play a task in supporting women's health, the present situation offers two serious problems.
Protection and Code: Licensed products, standard food guidelines, or without long -term protective data, use off -labels each patients and physicians In the uncertain area.
Access and inequality: Testosterone therapy isn't available through the NHS and is usually accessible through a personal clinic, which produces a two -level system. Those who will pay a whole bunch of kilos for consulting and prescriptions can access care, while Are left behind the other.
Innovation
There are signs of change. For example, I laid the foundation of the MadrentThe University of Warwick Spin Out Company, which is currently developing a testosterone patch, is specifically developed for girls. It is in Clinical trials And, if approved, the primary licensed testosterone product for girls within the UK in a decade can turn into a product. This is a vital step-and one which can pave the way in which for more innovation and wider access.
But the hurry stays. Millions of ladies are currently undergoing no effective, evidence -based care. In the meantime, off-label prescription ought to be used with maintenance and use that is predicated on the very best available science-not hip or story-and transparent, provided through regular health care channels.
Women deserve greater than work. They deserve the treatment they're designed for his or her bodies, strictly tested, which is approved by regulators and accessible to all – not only a number of individuals who can afford private care.
When half the population is affected, this is just not an issue. This is a priority.